With the pharmaceutical trade pursuing COVID-19 vaccines and coverings, researchers are keen to attach with potential trial patients to enroll in myriad research. TopicWell has launched a registry of patients which have indicated curiosity in taking part in such analysis, to assist contribute to growth of preventives and cures—by the top of May, the registry included greater than 67,000 motivated potential enrollees.
TopicWell CEO Ivor Clarke informed Outsourcing-Pharma that the COVID-19 has introduced unprecedented interruptions to the pharmaceutical trade, alongside with an pressing must develop a vaccine and different options.
“As clinical trials for a COVID-19 vaccine become more widely available, we know our partners across the industry will need to find trial participants quickly and efficiently,” Clarke informed us. “As part of regular business operations, our recruiters speak with thousands of patients each day prescreening them against the eligibility criteria for multiple Phase II-IV clinical trials; we found that nearly 80% of these people also wanted to volunteer to help combat COVID-19.”
Clarke additionally identified that accessing a sizeable record of potential trial members presents pharmaceutical firms and different stakeholders a possible shortcut to outcomes.
“The information from our COVID-19 patient registry list was developed to remove a large hurdle for our partners: access to interested patients and their medical information as they prepare to kick off widespread COVID-19 clinical research,” Clarke stated. “By sidestepping the lengthy process of identifying participants for a clinical trial, the list can help bring about a vaccine at a faster speed, impacting the decision makers, problem solvers and general public during the pandemic.”
Additionally, whereas the virus and pandemic have induced quite a lot of concern across the globe, the TopicWell registry consists of potential patients keen to courageous no matter dangers they could face to contribute towards an answer to the well being disaster.
“The COVID pandemic has clearly had an impact on the public’s awareness of clinical trials and on the willingness of individuals to participate,” Clarke explained. “We see this in the results of the ongoing survey that we have been conducting since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected; we also see it plainly reflected in the level of interest in the registry and in the types of comments we hear from patients who have registered.”
Clarke shared with OSP a number of the feedback patients supplied when enlisting within the registry:
- “Yes, if I can figure out a way to help and make progress, I would love to be a part of something that will better people.”
- “If it comes to being tested, taking medication, etc., I would love to share any information I can.”
- A affected person stated he was very involved about COVID-19 as he has relations which might be important staff and needs to take part so as to assist.
- “I would love to participate to help speed-up treatment and have the world gain knowledge about the virus.”
The TopicWell COVID-19 affected person registry provides researchers entry to people who may randomize for varied kinds of trials, whether or not they’re wholesome volunteers with no earlier publicity to COVID-19, at the moment sick with the virus, or who’ve recovered. Patient information consists of basic demographic info, current medical situations, previous virus diagnoses, previous publicity to the virus and outcomes of constructive antigen assessments.
By sidestepping the prolonged means of figuring out members for a scientific trial, in response to the corporate, the record will dramatically speed up final affected person in (LPI), which may in the end deliver a secure, authorized vaccine to most people quicker.